New Delhi [India], January 8 (ANI): Covaxin manufacture Bharat Biotech on Saturday said that the booster dose trials have shown "promising results" of long-term safety with "no serious adverse events".
Moscow [Russia], July 30 (ANI): Announcing the initial safety results of the world's first study of a combination of the AstraZeneca and Sputnik V COVID-19 vaccines, the Russian Direct Investment Fund (RDIF), on Friday said that interim analysis of the data demonstrates a high safety prof